Logo
O

OM1, Inc.

143 employees

OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research. We do things differently. We are pushing the boundaries of healthcare, reimagining how industry, providers, payers, and patients use real-world evidence. We are globally recognized for the integration of cutting-edge AI and data technologies. As pioneers in the field, our commitment to leveraging technology propels healthcare transformation, enhancing patient outcomes and setting new industry benchmarks.

Investor insights

Funding rounds participated in

$85M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Pharmaceutical Manufacturing

Sectors

Pharmaceutical Manufacturing

Date founded

2015

Funding rounds raised

Total raised

$85M

from 3 investors over 1 rounds

O

OM1, Inc. raised $85M on August 16, 2021

Investors: D1 Capital Partners, Breyer Capital and + 6 Other investors

FAQ